Multi-Parameter Chlamydia Trachomatis and Neisseria Gonorrhoeae NAATs Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033

Multi Parameter Chlamydia Trachomatis and Neisseria Gonorrhoeae NAATs Market Report Overview

The Multi-Parameter Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG) NAATs market size was valued at $1.06 billion in 2022. In women, Chlamydia Trachomatis infections are often asymptomatic, however, if left untreated they can cause pelvic inflammatory disease (PID), which in turn can lead to additional complications such as infertility, ectopic pregnancy, and chronic pelvic pain.

Multi-Parameter CT/NG NAATs Market Outlook 2022-2033 ($ Billion)

For more insights on the Multi-Parameter CT/NG NAATs market forecast, download a free sample report

The Multi Parameter CT/NG NAATs market research report is built to visualize quantitative market trends within in vitro diagnostics therapeutic areas. Furthermore, the model discusses in detail the impact of COVID-19 on the Multi Parameter CT/NG NAATs market for the year 2020 and beyond.

Multi Parameter CT/NG NAATs Market Dynamics

The Multi-parameter CT/NG NAATs market is expected to increase during the forecast period, largely sales increase in the North American region. In Europe and Asia Pacific, growth is expected to occur in select countries, however, this is expected to be partially counteracted by declines in large markets such as Italy, UK, Japan, and South Korea. The increasing incidences of Chlamydia and Gonorrhoea coupled with opportunistic screening tests provided by healthcare facilities are major drivers for the Multi-parameter CT/NG NAATs. However, factors that are expected to negatively impact the Multi-parameter CT/NG NAAT sales include changes to sexual and reproductive health service provision, decline in live birth rates, and competitive pricing pressure.

For additional Multi-Parameter CT/NG NAATs market dynamics, download a free sample report

Multi-Parameter CT/NG NAATs Market Segmentation by Regions

The key regions in the Multi-Parameter CT/NG NAATs market are Asia-Pacific, Europe, the Middle East and Africa, North America, and South and Central America. In 2022, North America emerged as the leading regional segment with the US being the largest contributor to the regional market.

The Multi-parameter CT/NG NAATs market is expected to grow strongly across all North American countries during the forecast period, with the strongest growth being forecast in the US. The growth of the US Multi-parameter CT/NG NAATs markets is largely being driven by increases in the number of infection and suspected infection cases. Sales of Multi-parameter CT/NG NAATs tests in these countries are also bolstered by a high proportion of pregnant women undergoing CT and NG screening. As such, increases in live birth rates are also expected to contribute to market growth.

Multi-Parameter CT/NG NAATs Market Analysis by Regions, 2022 (%)

For more regional insights in the Multi-Parameter CT/NG NAATs market, download a free sample report

Multi-Parameter CT/NG NAATs Market – Competitive Landscape

The key companies in the Multi Parameter CT/NG NAATs market are Abbott Laboratories, Becton Dickinson and Co, Danaher Corp, F. Hoffmann-La Roche Ltd, and Hologic Inc, among others. In 2022, Hologic Inc accounted for the highest Multi-Parameter CT/NG NAATs market share and value.

Multi-Parameter CT/NG NAATs Market Analysis by Companies, 2022 (%)

For more company insights into the Multi-Parameter CT/NG NAATs market, download a free sample report

Segments Covered in this Report.

Multi Parameter CT/NG NAATs Segment Outlook ($ Million, 2015-2033)

• Multi-parameter CT/NG NAATs
  • Overall

Multi Parameter CT/NG NAATs Regional Outlook ($ Million, 2015-2033)

• Asia-Pacific
• Europe
• Middle East and Africa
• North America
• South and Central America

Key Inclusions of the market model are –

Currently marketed Multi Parameter CT/NG NAATs market and evolving competitive landscape –

• Insightful review of the key industry trends.
• Annualized total Multi-Parameter CT/NG NAATs market revenue by segment and market outlooks from 2015-2033.
• Market-level data on units, average selling prices, and market values.

Global, Regional and Country level market specific insights –

• Qualitative market-specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
• SWOT analysis for the Multi-Parameter CT/NG NAATs market.
• Competitive dynamics insights and trends provided for the Multi-Parameter CT/NG NAATs market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country-specific overview of the healthcare system.
• Country-specific reimbursement policies.
• Country-specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real-world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Abbott Laboratories, Becton Dickinson and Co, Danaher Corp, F. Hoffmann-La Roche Ltd, Hologic Inc, and others.

Countries covered – United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for

• CMO executives who must have a deep understanding of the Multi-Parameter CT/NG NAATs marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to –

• Understand the impact of COVID-19 on Multi-Parameter CT/NG NAATs.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving Multi-Parameter CT/NG NAATs.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Multi-Parameter CT/NG NAATs market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company’s share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Multi-Parameter CT/NG NAATs market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.